UNIGE document Scientific Article
previous document  unige:24939  next document
add to browser collection
Title

Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study

Authors show hidden authors show all authors [1 - 41]
Published in Arthritis and Rheumatism. 2011, vol. 63, no. 6, p. 1486-96
Abstract To identify the determinants of antibody responses to adjuvanted split influenza A (H1N1) vaccines in patients with inflammatory rheumatic diseases.
Keywords Adjuvants, Immunologic/adverse effects/therapeutic useAdultAntibodies, Viral/blood/immunologyAntibody Formation/immunologyAntirheumatic Agents/immunologyArthritis, Rheumatoid/drug therapy/immunologyB-Lymphocytes/drug effects/immunologyFemaleHemagglutination Inhibition TestsHumansInfluenza A Virus, H1N1 Subtype/immunologyInfluenza Vaccines/adverse effects/immunology/therapeutic useMaleMiddle AgedSpondylarthritis/drug therapy/immunologyTumor Necrosis Factor-alpha/antagonists & inhibitors
Identifiers
PMID: 21384334
Full text
Article (Published version) (161 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research groups Mécanisme de l'inflammation articulaire (44)
Quorom-sensing et gènes de virulence (301)
Hépatologie chirurgicale (327)
Transplantation immunologie et osteoimmunologie (561)
Groupe Desmeules Jules (pharmacologie/toxicologie) (567)
Centre de vaccinologie et d'immunologie néonatale (177)
Epidémiologie clinique (115)
Groupe Seebach Jorg Dieter (transplantation et immunologie) (856)
Groupe Posfay-Barbe Clara (pédiatrie générale) (853)
Immunothérapie des cancers (42)
Unité HIV (46)
Groupe Desmeules Jules/Dayer Pierre (pharmacologie/toxicologie) (909)
Groupe Laurent Kaiser (virologie clinique) (668)
Citation
(ISO format)
GABAY, Cem et al. Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study. In: Arthritis and Rheumatism, 2011, vol. 63, n° 6, p. 1486-96. https://archive-ouverte.unige.ch/unige:24939

258 hits

2 downloads

Update

Deposited on : 2013-01-03

Export document
Format :
Citation style :